#HVO hVIVO PLC – Annual Report & Notice of AGM April 17, 2026 – Posted in: hVIVO (HVO)

London, UK – 17 April 2026, hVIVO plc (AIM: HVO), a purpose-built, full-service international clinical development partner and the world leader in human challenge trials, confirms that the Company’s Annual Report and Accounts for the year ended 31 December 2025 and the Notice of Annual General Meeting (“AGM”) will be posted to shareholders today.   The 2025 Annual Report and Accounts, the Notice of AGM and accompanying form of proxy are available to download from the Company’s website: www.hvivo.com.  …

Continue reading

#HVO hVIVO PLC – Annual Report, Notice of AGM & Directorate Change May 12, 2025 – Posted in: hVIVO (HVO)

hVIVO plc (AIM: HVO), a full-service Contract Research Organisation (CRO) and the world leader in human challenge clinical trials, confirms that the Company’s Annual Report and Accounts for the year ended 31 December 2024 and the Notice of Annual General Meeting (“AGM”) will be posted to shareholders today.   The 2024 Annual Report and Accounts, the Notice of AGM and accompanying form of proxy are available to download from the Company’s website www.hvivo.com.   The Annual…

Continue reading

#TSP TruSpine Technologies PLC – AGM Statement April 10, 2025 – Posted in: TruSpine Plc (TSP)

TruSpine Technologies Plc, the medical device company focused on the spinal (vertebral) stabilisation market, announces that Geoff Miller, Non-executive Chairman of the Company, will provide the following statement at its annual general meeting to be held today:   “Over the year since I joined the TruSpine Board, we have sought to refocus the Company on delivering value for shareholders. I am pleased to report that considerable progress has been made in this regard.   The…

Continue reading

#VELA investee co. #CSFS Cornerstone FS PLC – Interim Results September 12, 2023 – Posted in: Blog, Vela Technologies Plc (VELA)

Cornerstone FS plc (AIM: CSFS), a foreign exchange and payments solutions company offering multi-currency accounts to businesses and individuals through its proprietary technology platform, is pleased to announce its unaudited interim results for the six months ended 30 June 2023.   Financial Highlights ·    Revenue increased by 90% to £3.6m (H1 2022: £1.9m) through the continued expansion of the Group’s payments capabilities and offering, and on-going investment in the sales function ·    Gross margin broadly…

Continue reading

#HVO hVIVO PLC – Interim results – Posted in: Blog, hVIVO (HVO)

hVIVO plc (AIM & Euronext: HVO), the world leader in testing infectious and respiratory disease products using human challenge clinical trials, announces its unaudited interim results for the six-month period ended 30 June 2023.   Financial highlights ·    First half revenue growth of 52% to £27.3 million* (H1 2022: £18.0 million) ·    EBITDA more than doubled to £5.2 million (H1 2022: £2.3 million) ·    EBITDA margin increased to 19.1% (H1 2022: 12.6%) ·    Net cash…

Continue reading

#VELA investee #CSFS Cornerstone FS Plc – Final Results for the Year Ended 31 December 2022 May 16, 2023 – Posted in: Blog, Vela Technologies Plc (VELA)

Cornerstone FS Plc (AIM: CSFS), a foreign exchange and payments company offering multi-currency accounts to businesses and individuals, announces its final results for the year ended 31 December 2022. In addition, the Company gives notices of its annual general meeting (“AGM”) and publication of its annual report and accounts, both of which are being posted on the Company’s website at: https://investors.cornerstonefs.com/document-centre/.   Highlights ·    Revenue increased 110% to £4.8m (2021: £2.3m) ·    Gross margin improved…

Continue reading

#POLB Poolbeg Pharma PLC – Results of Annual General Meeting May 11, 2023 – Posted in: Uncategorized

11 May 2023 – Poolbeg Pharma (AIM: POLB, OTCQB: POLBF, ‘Poolbeg’ or the ‘Company’), a leading biopharmaceutical company focusing on infectious and prevalent diseases with a high unmet medical need, announces that at the Annual General Meeting held at 12:00pm today, all resolutions were duly passed.   – Ends –   Enquiries Poolbeg Pharma Plc Jeremy Skillington, CEO Ian O’Connell, CFO   +44 (0) 207 183 1499 finnCap Ltd (Nominated Adviser & Joint Broker) Geoff Nash, Charlie Beeson, Nigel Birks, Harriet Ward (ECM)  …

Continue reading

#HVO hVIVO PLC – Annual Report and Notice of AGM April 28, 2023 – Posted in: hVIVO (HVO)

hVIVO plc (AIM & Euronext: HVO), (formerly Open Orphan plc) a rapidly growing specialist contract research organisation (CRO) and world leader in testing infectious and respiratory disease products using human challenge clinical trials, confirms that the Company’s Annual Report and Accounts for the year ended 31 December 2022 and the Notice of Annual General Meeting (“AGM”) will be posted to shareholders today.   The 2022 Annual Report and Accounts, the Notice of AGM and accompanying form…

Continue reading

Vela Technologies #VELA – Result of AGM October 25, 2022 – Posted in: Blog, Vela Technologies Plc (VELA)

The Board of Vela (AIM: VELA) announces that at its Annual General Meeting (“AGM”) held earlier today, all resolution were duly passed save for resolution 5. Resolution 5, to re-appoint Antony Laiker as a Director of the Company, was not put to the meeting as Antony Laiker has stepped down from the board of the Company, as announced on 20 October 2022. The proxy voting results of the Resolutions are set out below: Resolutions at…

Continue reading

#VELA Vela Technologies plc – Investee Company #ENSI EnSilica plc – Final Results October 17, 2022 – Posted in: Vela Technologies Plc (VELA)

EnSilica (AIM: ENSI), a leading mixed signal chipmaker announces full year results for the year ended 31 May 2022 (“FY 22”).   Financial highlights   ·   Revenue up 77% to £15.3 million (FY21: £8.6 million) ·   Adjusted operating profit £0.70 million (FY21 £0.17 million loss). ·   Gross margin 33% (FY21: 23.9%) ·   Adjusted EBITDA up significantly to £1.05 million (FY21: £0.06 million) ·   Cash and cash equivalents at 31 May 2022 of £5.7 million (31 May 2021: £1.4 million) ·   Net…

Continue reading